Eric S. Fain - 26 Jun 2025 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role: Director
Signature: /s/ Andrew Taylor, Attorney-in-Fact
Issuer symbol: OBIO
Transactions as of: 26 Jun 2025
Net transactions value: -$8,183
Form type: 4
Filing time: 27 Jun 2025, 17:10:00 UTC
Previous filing: 26 Jun 2025
Next filing: 08 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Fain Eric S	Director	C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE	/s/ Andrew Taylor, Attorney-in-Fact	27 Jun 2025	0001402222

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OBIO	Common Stock, par value $0.0001 per share ("Common Stock")	Sale	$8,183	-2,683	-5%	$3.05	50,949	26 Jun 2025	By the Fain Living Trust	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares reported as disposed herein were granted on June 20, 2024 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
F2	The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.98 to $3.11, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The shares reported as disposed herein were granted on June 20, 2024 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.

The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.98 to $3.11, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.